INM logo

InMed Pharmaceuticals (INM) Retained Earnings

Annual Retained Earnings

-$109.08 M
-$7.68 M-7.57%

June 30, 2024


Summary


Performance

INM Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMbalance sheetmetrics:

Quarterly Retained Earnings

-$110.75 M
-$1.68 M-1.54%

September 30, 2024


Summary


Performance

INM Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

INM Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-7.6%-3.4%
3 y3 years-45.7%-18.5%
5 y5 years-121.8%-61.7%

INM Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.7%at low-34.9%at low
5 y5-year-121.8%at low-111.9%at low
alltimeall time-1212.0%at low-1164.3%at low

InMed Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$110.75 M(+1.5%)
Jun 2024
-$109.08 M(+7.6%)
-$109.08 M(+1.8%)
Mar 2024
-
-$107.14 M(+1.6%)
Dec 2023
-
-$105.42 M(+1.4%)
Sep 2023
-
-$103.94 M(+2.5%)
Jun 2023
-$101.40 M(+8.5%)
-$101.40 M(+0.3%)
Mar 2023
-
-$101.06 M(+2.0%)
Dec 2022
-
-$99.06 M(+2.2%)
Sep 2022
-
-$96.96 M(+3.8%)
Jun 2022
-$93.45 M(+24.8%)
-$93.45 M(+9.2%)
Mar 2022
-
-$85.58 M(+4.2%)
Dec 2021
-
-$82.11 M(+5.5%)
Sep 2021
-
-$77.82 M(+4.0%)
Jun 2021
-$74.85 M(+15.8%)
-$74.85 M(+4.6%)
Mar 2021
-
-$71.59 M(+4.5%)
Dec 2020
-
-$68.49 M(+3.4%)
Sep 2020
-
-$66.25 M(+2.5%)
Jun 2020
-$64.65 M(+31.4%)
-$64.65 M(+23.7%)
Mar 2020
-
-$52.26 M(-4.3%)
Dec 2019
-
-$54.59 M(+5.6%)
Sep 2019
-
-$51.71 M(+5.1%)
Jun 2019
-$49.19 M(+26.1%)
-$49.19 M(+8.9%)
Mar 2019
-
-$45.16 M(+8.3%)
Dec 2018
-
-$41.71 M(-0.5%)
Sep 2018
-
-$41.92 M(+7.4%)
Jun 2018
-$39.02 M(+18.6%)
-$39.02 M(+4.4%)
Mar 2018
-
-$37.39 M(+1.9%)
Dec 2017
-
-$36.71 M(+2.1%)
Sep 2017
-
-$35.96 M(+9.3%)
Jun 2017
-$32.90 M(+11.1%)
-$32.90 M(+7.2%)
Mar 2017
-
-$30.68 M(+3.9%)
Dec 2016
-
-$29.52 M(+0.2%)
Sep 2016
-
-$29.46 M(-0.5%)
Jun 2016
-$29.62 M(+2.3%)
-$29.62 M(+1.7%)
Mar 2016
-
-$29.13 M(+8.1%)
Dec 2015
-
-$26.96 M(-1.2%)
Sep 2015
-
-$27.29 M(-5.8%)
Jun 2015
-$28.96 M(-2.4%)
-$28.96 M(+6.4%)
Mar 2015
-
-$27.21 M(-3.9%)
Dec 2014
-
-$28.31 M(-2.2%)
Sep 2014
-
-$28.94 M(-2.4%)
Jun 2014
-$29.67 M(+2.6%)
-$29.67 M(+7.3%)
Mar 2014
-
-$27.66 M(-3.4%)
Dec 2013
-
-$28.62 M(-3.0%)
Sep 2013
-
-$29.50 M(+2.0%)
Jun 2013
-$28.91 M
-$28.91 M(-3.2%)
Mar 2013
-
-$29.88 M(-2.2%)
DateAnnualQuarterly
Dec 2012
-
-$30.55 M(-1.1%)
Sep 2012
-
-$30.88 M(+3.4%)
Jun 2012
-$29.86 M(-4.2%)
-$29.86 M(-1.6%)
Mar 2012
-
-$30.34 M(+2.4%)
Dec 2011
-
-$29.63 M(+1.7%)
Sep 2011
-
-$29.12 M(-6.5%)
Jun 2011
-$31.16 M(+10.0%)
-$31.16 M(+0.4%)
Mar 2011
-
-$31.04 M(+3.6%)
Dec 2010
-
-$29.95 M(+3.3%)
Sep 2010
-
-$29.00 M(+2.3%)
Jun 2010
-$28.33 M(+11.5%)
-$28.33 M(-3.0%)
Mar 2010
-
-$29.21 M(+3.0%)
Dec 2009
-
-$28.35 M(+2.4%)
Sep 2009
-
-$27.69 M(+8.9%)
Jun 2009
-$25.42 M(-8.5%)
-$25.42 M(+7.9%)
Mar 2009
-
-$23.55 M(-3.2%)
Dec 2008
-
-$24.34 M(-12.1%)
Sep 2008
-
-$27.68 M(-0.4%)
Jun 2008
-$27.79 M(+8.2%)
-$27.79 M(+2.0%)
Mar 2008
-
-$27.25 M(-3.7%)
Dec 2007
-
-$28.30 M(+1.8%)
Sep 2007
-
-$27.81 M(+8.3%)
Jun 2007
-$25.68 M(+11.9%)
-$25.68 M(+25.0%)
Mar 2007
-
-$20.54 M(+2.2%)
Dec 2006
-
-$20.10 M(-13.3%)
Sep 2006
-
-$23.20 M(+1.0%)
Jun 2006
-$22.96 M(+16.4%)
-$22.96 M(+5.4%)
Mar 2006
-
-$21.80 M(+1.7%)
Dec 2005
-
-$21.43 M(+1.3%)
Sep 2005
-
-$21.14 M(+7.2%)
Jun 2005
-$19.73 M(+26.4%)
-$19.73 M(+6.1%)
Mar 2005
-
-$18.59 M(+1.1%)
Dec 2004
-
-$18.38 M(+7.1%)
Sep 2004
-
-$17.16 M(+10.0%)
Jul 2004
-$15.61 M(+16.9%)
-$15.61 M(+7.8%)
Apr 2004
-
-$14.48 M(-1.7%)
Jan 2004
-
-$14.73 M(+1.8%)
Oct 2003
-
-$14.47 M(+8.5%)
Jul 2003
-$13.35 M(+24.2%)
-$13.35 M(+5.2%)
Apr 2003
-
-$12.69 M(+8.0%)
Jan 2003
-
-$11.75 M(+4.8%)
Oct 2002
-
-$11.22 M(+4.4%)
Jul 2002
-$10.74 M(+29.2%)
-$10.74 M(+4.6%)
Apr 2002
-
-$10.27 M(+8.2%)
Jan 2002
-
-$9.50 M(+8.4%)
Oct 2001
-
-$8.76 M
Jul 2001
-$8.31 M
-

FAQ

  • What is InMed Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual retained earnings year-on-year change?
  • What is InMed Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly retained earnings year-on-year change?

What is InMed Pharmaceuticals annual retained earnings?

The current annual retained earnings of INM is -$109.08 M

What is the all time high annual retained earnings for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual retained earnings is -$8.31 M

What is InMed Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, INM annual retained earnings has changed by -$7.68 M (-7.57%)

What is InMed Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of INM is -$110.75 M

What is the all time high quarterly retained earnings for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly retained earnings is -$8.76 M

What is InMed Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, INM quarterly retained earnings has changed by -$3.62 M (-3.37%)